Discharge Aspirin Dose and Clinical Outcomes in Patients With Acute Coronary Syndromes Treated With Prasugrel Versus Clopidogrel-Reference-Cited by-同舟云学术

Discharge Aspirin Dose and Clinical Outcomes in Patients With Acute Coronary Syndromes Treated With Prasugrel Versus Clopidogrel

Published:2014-01 Issue:3 Volume:63 Page:225-232
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kohli Payal,Udell Jacob A.,Murphy Sabina A.,Cannon Christopher P.,Antman Elliott M.,Braunwald Eugene,Wiviott Stephen D.

Funder

Eli Lilly and Company, Daiichi Sankyo, and Sanofi-Aventis

Accumetrics, AstraZeneca, CSL Behring, Essentialis, Inc., GlaxoSmithKline, Merck & Co., Inc., Regeneron Pharmaceuticals, Inc., Sanofi, and Takeda

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2;Lancet,1988

2. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group;Lancet,1990

3. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study;Lewis;N Engl J Med,1983

4. Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?;Glasser;Prev Med,2008

5. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions;Levine;J Am Coll Cardiol,2011

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients;JAMA Cardiology;2024-09-01

2. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors;Journal of the American Heart Association;2023-10-17

3. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

4. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease;New England Journal of Medicine;2021-05-27

5. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease;NEW ENGL J MED;2021